# OPTIA-AF Trial: Rhythm-Guided Antithrombotic Strategy After AF Ablation

> **NCT07496281** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Ewha Womans University Mokdong Hospital** · enrollment: 2 (estimated)

## Conditions studied

- Atrial Fibrillation (AF)
- Coronary Artery Disease
- Drug-eluting Stent

## Interventions

- **DRUG:** Oral anticoagulation
- **DRUG:** Single antiplatelet therapy

## Key facts

- **NCT ID:** NCT07496281
- **Lead sponsor:** Ewha Womans University Mokdong Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2027-03-01
- **Primary completion:** 2032-02-28
- **Final completion:** 2035-03-01
- **Target enrollment:** 2 (ESTIMATED)
- **Last updated:** 2026-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07496281

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07496281, "OPTIA-AF Trial: Rhythm-Guided Antithrombotic Strategy After AF Ablation". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT07496281. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*